298 related articles for article (PubMed ID: 113086)
21. Reduction of epoxy derivatives of benzo(a)pyrene by microsomal cytochrome P-450.
Sugiura M; Yamazoe Y; Kamataki ; Kato R
Cancer Res; 1980 Aug; 40(8 Pt 1):2910-4. PubMed ID: 6771009
[No Abstract] [Full Text] [Related]
22. Modification of benzo(a)pyrene metabolism in hepatic microsomes from untreated and induced rats by imidazole derivatives which inhibit monooxygenase activity and enhance epoxide hydrolase activity.
James MO; Little PJ
Drug Metab Dispos; 1983; 11(4):350-4. PubMed ID: 6137342
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of microsomal metabolism and chemical oncogenesis in culture by naphthalene quinones.
Nesnow S; Bergman H; Garland H; Morris M
J Environ Pathol Toxicol; 1980 Nov; 4(5-6):17-30. PubMed ID: 7217845
[TBL] [Abstract][Full Text] [Related]
24. The role of microsomes and nuclear envelope in the metabolic activation of benzo(a)pyrene leading to binding with nuclear macromolecules.
Pezzuto JM; Lea MA; Yang CS
Cancer Res; 1977 Sep; 37(9):3427-33. PubMed ID: 884686
[No Abstract] [Full Text] [Related]
25. Covalent binding of benzo[a]pyrene to cytochrome P-450 beta NF-B2 and other proteins in reconstituted mixed-function oxidase systems.
Schelin C; Wallin H; Halpert J; Jergil B
Chem Biol Interact; 1984 May; 49(3):269-81. PubMed ID: 6327095
[TBL] [Abstract][Full Text] [Related]
26. Comparative benzo[a]pyrene metabolite patterns in fish and rodents.
Melius P
Natl Cancer Inst Monogr; 1984 May; 65():387-90. PubMed ID: 6087145
[TBL] [Abstract][Full Text] [Related]
27. Modifications of microsomal and nuclear fractions by butylated hydroxyanisole and its effect on benzo(a)pyrene metabolites binding to macromolecules.
Demkowicz-Dobrzański KK; Hennig EE; Juśkiewicz-Skiba M; Piekarski L
Neoplasma; 1984; 31(4):423-30. PubMed ID: 6089009
[TBL] [Abstract][Full Text] [Related]
28. Product inhibition of benzo[a]pyrene metabolism in uninduced rat liver microsomes: effect of diol epoxide formation.
Keller GM; Christou M; Pottenger LH; Wilson NM; Jefcoate CR
Chem Biol Interact; 1987 Feb; 61(2):159-75. PubMed ID: 3103934
[TBL] [Abstract][Full Text] [Related]
29. The isolation of rat intestinal microsomes with stable cytochrome P-450 and their metabolism of benzo(alpha) pyrene.
Stohs SJ; Grafström RC; Burke MD; Moldéus PW; Orrenius SG
Arch Biochem Biophys; 1976 Nov; 177(1):105-16. PubMed ID: 826220
[No Abstract] [Full Text] [Related]
30. Fluorescence study of DNA-binding metabolites of benzo(a)pyrene formed in hepatocytes isolated from 3-methylcholanthrene-treated rats.
Jernström B; Orrenius S; Undeman O; Gräslund A; Ehrenberg A
Cancer Res; 1978 Aug; 38(8):2600-7. PubMed ID: 667854
[TBL] [Abstract][Full Text] [Related]
31. Effects of inhibition of NADPH: cytochrome P-450 reductase on benzo(a)pyrene metabolism in mouse liver microsomes.
Byczkowski JZ; Gessner T
Int J Biochem; 1989; 21(5):525-9. PubMed ID: 2503403
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides.
Thakker DR; Yagi H; Lu AY; Levin W; Conney AH
Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3381-5. PubMed ID: 1068451
[TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of three forms of microsomal cytochrome P-450 in liver from 3-methylcholanthrene-treated guinea pigs.
Abe T; Watanabe M
Mol Pharmacol; 1983 Jan; 23(1):258-64. PubMed ID: 6306424
[TBL] [Abstract][Full Text] [Related]
34. Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.
Kahl R; Friederici DE; Kahl GF; Ritter W; Krebs R
Drug Metab Dispos; 1980; 8(4):191-6. PubMed ID: 6105049
[TBL] [Abstract][Full Text] [Related]
35. Comparison of epoxide and free-radical mechanisms for activation of benzo[a]pyrene by Sprague-Dawley rat liver microsomes.
Selkirk JK
J Natl Cancer Inst; 1980 Apr; 64(4):771-4. PubMed ID: 6928990
[TBL] [Abstract][Full Text] [Related]
36. The liver microsomal hydroxylation enzyme system. Induction and properties of the functional components.
Lu AY; Kuntzman R; Conney AH
Front Gastrointest Res; 1976; 2():1-31. PubMed ID: 819342
[No Abstract] [Full Text] [Related]
37. Monoclonal antibody characterization of NADH- and NADPH-dependent hydroxylation of benzo(a)pyrene in liver microsomes from 5,6-benzoflavone-induced C57Bl/6 mice.
Brauze D; Mikstacka R; Pelkonen O
Acta Biochim Pol; 1990; 37(2):219-25. PubMed ID: 2072980
[TBL] [Abstract][Full Text] [Related]
38. Cytochrome P450 dependent monooxygenases in nasal epithelial membranes: effect of phenobarbital and benzo(A)pyrene.
Hadley WM; Dahl AR; Benson JM; Hahn FF; McClellan RO
Proc West Pharmacol Soc; 1982; 25():197-9. PubMed ID: 6289337
[No Abstract] [Full Text] [Related]
39. Benzo(a)pyrene activation to 7,8-dihydrodiol 9,10-oxide by rat liver microsomes. Control by selective product inhibition.
Keller GM; Jefcoate CR
J Biol Chem; 1984 Nov; 259(22):13770-6. PubMed ID: 6438082
[TBL] [Abstract][Full Text] [Related]
40. Effect of vitamin A deficiency on pulmonary and hepatic in vitro metabolism of benzo(a)pyrene in rat.
Dogra SC; Khanduja KL; Sharma RR; Hom T; Varanasi U
Biochem Int; 1985 Dec; 11(6):869-84. PubMed ID: 3937530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
